To get a GLP-1 prescription online in California, you complete a health questionnaire, a California-licensed clinician reviews it — usually by secure message, not a scheduled video call — and if they determine treatment is appropriate, a licensed pharmacy fills the prescription and ships it to your address. California is one of the states where the entire process can happen asynchronously: no commute, no waiting room, and for most patients, no video visit at all. See our state page for California for current availability and pricing, or read on for exactly how the process works and what's specific to California residents.
The short answer
California allows a licensed clinician to establish care and prescribe a GLP-1 like semaglutide or tirzepatide entirely through an online intake and secure messaging — no video visit is required by state rule. The clinician reviewing your case must hold an active California medical license (or, for nurse practitioners, California prescriptive authority); an out-of-state license isn't enough. Both compounded and FDA-approved brand-name GLP-1s are available through the same intake, and eligibility is always a clinical decision, never automatic.
How does the online intake work for California residents?
The mechanics are the same questionnaire-then-review process used everywhere, but two details are California-specific: who's allowed to review your case, and how that review can happen.
- You complete an intake questionnaire. Medical history, current medications, prior GLP-1 use, and your goals — typically 5–10 minutes from a phone or computer.
- A California-licensed clinician reviews it. California requires any provider prescribing to a California resident to hold an active California medical license — a license from another state doesn't qualify, even for an otherwise identical telehealth visit. Nurse practitioners can also prescribe: most California NPs furnish medications under physician-approved standardized procedures, and NPs certified under AB 890 can now practice — including prescribing — independently for the most experienced tier, as of January 2026.
- The clinician decides whether treatment is appropriate. This is a clinical judgment based on your history and goals, not a guarantee tied to submitting a form.
- A licensed pharmacy fills the prescription. Compounded preparations are prepared per-patient by a US-licensed compounding pharmacy; FDA-approved brand-name medications are filled by a licensed pharmacy that dispenses the commercially manufactured product.
- It ships to your California address, typically within a couple of business days of the pharmacy filling the order — whether you're in Los Angeles, San Diego, the Bay Area, Sacramento, or a smaller California ZIP code, the process and the price are the same.
For the full national walkthrough of each step — including what disqualifies someone and how to vet a provider — see how a GLP-1 prescription online actually works. This piece focuses on what changes when you're a California resident.
Do I need a video visit in California?
No. California is one of the roughly seven in eight states where the entire process — intake, clinician review, prescribing decision, and follow-up — can happen asynchronously by secure message. California's telehealth guidance permits a licensed physician to establish the provider-patient relationship and prescribe non-controlled medications like GLP-1s through either synchronous video or store-and-forward (asynchronous) review, as long as the standard of care is met. GLP-1 medications are not controlled substances, so California's stricter controlled-substance telemedicine rules don't apply to them.
That said, "no video call required" isn't a promise that nothing will ever prompt one. Depending on your intake — a complex medical history, an unclear detail worth clarifying — a clinician may ask for a brief video visit or additional labs before prescribing. Most patients complete everything asynchronously, but the clinician's judgment about what your case needs comes first.
Check your eligibility in California
Complete a short health questionnaire and a California-licensed clinician will review whether a GLP-1 is appropriate for you — most patients never need to schedule a video call.
Start your intake →Compounded vs. brand-name GLP-1s in California
Pallas offers both tiers to California residents through the same intake, and they're worth telling apart:
- Compounded semaglutide and tirzepatide — including a microdose option and, for semaglutide, an oral tablet — prepared per-patient by US-licensed compounding pharmacies under FDCA §503A, prescribed when a California-licensed clinician documents a patient-specific clinical rationale.
- FDA-approved brand-name medications — Wegovy® and Ozempic® (semaglutide, Novo Nordisk), Zepbound® and Mounjaro® (tirzepatide, Eli Lilly) — the same commercially manufactured products sold at any retail pharmacy, prescribed when a clinician determines they're appropriate. Brand-name prescriptions through Pallas are cash-pay only and are not billed to insurance.
Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.
Neither tier is "better" in the abstract — which one a clinician recommends depends on your history, goals, and what's clinically appropriate for you, and some patients move between tiers over time. What doesn't change between them is the review itself: both paths go through the same real clinician, licensed to prescribe in California, before anything ships. For a deeper look at how the two compare nationally, see our compounded vs. brand-name GLP-1 guide; for tirzepatide specifically, see how to get tirzepatide online.
Does Medi-Cal or insurance cover GLP-1s in California?
Not for weight loss. Medi-Cal removed Wegovy®, Zepbound®, and Saxenda® from coverage for weight-loss indications for members 21 and older effective January 1, 2026, keeping coverage only for type 2 diabetes plus narrow exceptions (Wegovy® for cardiovascular risk reduction or MASH; Zepbound® for obstructive sleep apnea). Compounded semaglutide and tirzepatide are not covered by Medi-Cal at all. Pallas is a cash-pay telehealth service — no insurance is billed for either tier — so this doesn't change how the intake or pricing works with us, but it's worth knowing if you were assuming Medi-Cal coverage applied. For current pricing, see what compounded semaglutide costs and the California state page.
Is compounded semaglutide available in California?
Yes — compounded semaglutide is available to eligible California residents through licensed telehealth. It's prepared per-patient by a US-licensed compounding pharmacy under FDCA §503A, and a California-licensed clinician must prescribe it based on a documented, patient-specific clinical rationale rather than cost or preference alone. FDA-approved brand-name options are available through the same intake if a compounded preparation isn't the right fit for you.
What should I check before choosing an online provider in California?
The same red flags apply in California as everywhere else, plus one California-specific check:
- A California medical license, verifiable. Ask, or check the Medical Board of California's license lookup. An out-of-state license doesn't satisfy California's requirement, no matter how the provider markets itself.
- A real intake and clinician review — not just a payment form. If a site skips straight to checkout, it isn't practicing medicine in California or anywhere else.
- A named, licensed pharmacy. A legitimate provider can tell you which pharmacy — retail or compounding — prepares and ships your medication.
- Verifiable LegitScript certification. LegitScript maintains a public database of certified healthcare merchants. Pallas is LegitScript Healthcare Merchant Certified, and you can look up any provider before paying.
The bottom line
California residents can get a GLP-1 prescription online through a real clinical process: an intake questionnaire, review by a California-licensed clinician (physician or NP), a prescribing decision based on your history, and fulfillment through a licensed pharmacy that ships to your address in a few business days. No video visit is required by state rule, both compounded and FDA-approved brand-name options are available, and Medi-Cal no longer covers GLP-1s for weight loss as of 2026. Learn more about GLP-1 treatment at Pallas or start with the California state page for current specifics.
Frequently asked questions
No — California is asynchronous-first. A California-licensed provider can review your intake by secure message and, if appropriate, prescribe semaglutide or tirzepatide without ever scheduling a video call, as long as the standard of care is met. A provider may ask for a brief video visit or additional labs if your history calls for it, but most patients complete everything asynchronously.
Yes — compounded semaglutide is available to eligible California residents through licensed telehealth. It's prepared per-patient by US-licensed compounding pharmacies under FDCA §503A, and a California-licensed clinician must prescribe it based on a documented, patient-specific clinical rationale. FDA-approved brand-name options like Wegovy® and Zepbound® are also available through the same intake.
Yes. Most California nurse practitioners prescribe (the state's legal term is furnishing) under physician-approved standardized procedures, and NPs certified under AB 890 can practice without them — including, as of January 2026, fully independent practice for the most experienced tier. Semaglutide and tirzepatide aren't controlled substances, so California permits the entire process — intake, prescription, and follow-up — through telehealth, as long as the treating clinician holds active California prescriptive authority.
Not anymore. Medi-Cal removed Wegovy®, Zepbound®, and Saxenda® from coverage for weight-loss indications for members 21 and older effective January 1, 2026, keeping GLP-1 coverage for type 2 diabetes plus narrow exceptions (Wegovy® for cardiovascular risk reduction or MASH; Zepbound® for obstructive sleep apnea). Compounded semaglutide and tirzepatide were never covered by Medi-Cal. Pallas is a cash-pay service, so this doesn't change your intake or pricing with us either way.
Procedurally, not clinically — both go through the same California-licensed clinician review before anything is prescribed. Compounded semaglutide and tirzepatide are prepared per-patient by US-licensed compounding pharmacies under FDCA §503A when a clinician documents a patient-specific clinical rationale; FDA-approved brand-name products (Wegovy®, Ozempic®, Zepbound®, Mounjaro®) are the same commercially manufactured medications sold at any retail pharmacy. Which one a clinician recommends depends on your history and goals, and brand-name prescriptions through Pallas are cash-pay only.
Yes. Telehealth intake, clinician review, and pharmacy fulfillment work the same whether you're in Los Angeles, San Diego, the Bay Area, Sacramento, or a smaller California town — the online process doesn't vary by ZIP code, and neither does the price. What varies is only how quickly you complete your own intake.
See if you qualify in California
Pallas's intake is asynchronous for California residents — complete it by message, and a California-licensed clinician will let you know if a GLP-1 is appropriate for you. No insurance needed, cancel anytime.
Start your intake →Trademarks & disclosures
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. Pallas is not affiliated with, endorsed by, or sponsored by either manufacturer. Brand-name GLP-1 medications dispensed through Pallas are cash-pay only and are not billed to insurance. Prescriptions — brand-name or compounded — are written only when a California-licensed clinician determines treatment is appropriate.